Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway

OBJECTIVE: Protein convertase subtilisin/Kexin type 9 (PCSK9) has been found to be closely associated with the occurrence and development of numerous tumors. However, the precise role of PCSK9 and its relationship to the development of hepatocellular carcinoma (HCC) remain largely unknown. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Mingyan, Hu, Jing, Fang, Tingting, Tang, Wenqing, Lv, Bei, Yang, Biwei, Xia, Jinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763006/
https://www.ncbi.nlm.nih.gov/pubmed/33893729
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763006/
https://www.ncbi.nlm.nih.gov/pubmed/33893729
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0313

Ejemplares similares